These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Hemodynamic effects of a new calcium antagonist, bepridil, in patients with coronary artery disease]. Haerer VW, Stauch M. Arzneimittelforschung; 1987 Jul; 37(7):829-31. PubMed ID: 3499908 [Abstract] [Full Text] [Related]
7. Hemodynamic effects of intravenous bepridil in patients with normal left ventricular function. Alpert JS, Benotti JR, Brady PM, McCue JE, Weiner BH, Ockene IS. Am J Cardiol; 1985 Mar 15; 55(7):20C-24C. PubMed ID: 3872053 [Abstract] [Full Text] [Related]
8. Hemodynamic actions of bepridil during treatment of stable angina pectoris. Narahara KA, Shapiro W, Weliky I, Park J. Am J Cardiol; 1985 Mar 15; 55(7):55C-58C. PubMed ID: 3883742 [Abstract] [Full Text] [Related]
13. Evaluation of bepridil, a new antianginal agent: clinical and hemodynamic alterations during the treatment of stable angina pectoris. Narahara KA, Shapiro W, Weliky I, Park J. Am J Cardiol; 1984 Jan 01; 53(1):29-34. PubMed ID: 6419578 [Abstract] [Full Text] [Related]
17. Alterations in contrast medium-induced coronary reactive hyperemia after bepridil in patients with coronary artery disease. Foult JM, Nitenberg A, Blanchet F, Zouiouèche S, Huyghebaert MF. Am Heart J; 1985 Feb 01; 109(2):244-51. PubMed ID: 3871297 [Abstract] [Full Text] [Related]
18. Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease. Côté P, Bourassa MG, Tubau JF, Enjalbert M, Vandormael M. Clin Cardiol; 1984 Jan 01; 7(1):14-22. PubMed ID: 6705283 [Abstract] [Full Text] [Related]